What is Blume?
Based in Canada, Blume specializes in the development and distribution of superfood lattes and gut-health-focused beverages. By prioritizing clean-label ingredients and low-sugar formulations, the company addresses the growing consumer demand for functional nutrition that integrates seamlessly into daily wellness rituals. Blume distinguishes itself through a commitment to inclusivity and a judgment-free approach to health, positioning its product line as a versatile solution for modern consumers seeking plant-based alternatives to traditional caffeinated or sugary drinks. The firm's operational model leverages a strong community-centric brand identity to drive customer loyalty and repeat engagement in the rapidly expanding wellness beverage market.
How much funding has Blume raised?
Blume has raised a total of $30K across 1 funding round:
Private Equity
$30K
Private Equity (2026): $30K, investors not publicly disclosed
Key Investors in Blume
Undisclosed Investor
An institutional investment firm focused on scaling high-growth consumer packaged goods and wellness brands.
What's next for Blume?
With the acquisition of this substantial expansion capital, Blume is well-positioned to execute its next phase of growth, which likely includes scaling its supply chain, expanding retail distribution channels, and investing in product innovation. As the company navigates the complexities of the Series B/C stage, the focus will shift toward optimizing operational efficiencies and capturing a larger share of the health-conscious demographic. By leveraging its established brand equity, Blume aims to solidify its market leadership, potentially exploring new product categories that align with its core mission of promoting holistic wellness through accessible, high-quality superfood offerings.
See full Blume company page
